These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3631686)

  • 21. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
    Hamilton-Miller JM; Patel R; Brumfitt W
    Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cefotaxime, syn isomer of a new methoxyimino cephalosporin with unusual activity (author's transl)].
    Chabbert YA; Lutz A
    Nouv Presse Med; 1981 Feb; 10(8):541-4. PubMed ID: 6259588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of bacterial isolates to cefepime in comparison to other broad spectrum antimicrobial agents at a tertiary care center in Lebanon.
    Kanj SS; Chedid M; Araj GF
    J Med Liban; 2001; 49(1):13-7. PubMed ID: 11910959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftezole, a new cephalosporin C derivative I. In vitro and in vivo antimicrobial activity.
    Noto T; Nehashi T; Endo H; Saito M; Matsubara S
    J Antibiot (Tokyo); 1976 Oct; 29(10):1058-70. PubMed ID: 994325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic activity of cefazedone in experimental pyelonephritis.
    Quante T; Ritzerfeld W
    Arzneimittelforschung; 1979; 29(2a):417-8. PubMed ID: 385010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark.
    Salmon SA; Watts JL; Case CA; Hoffman LJ; Wegener HC; Yancey RJ
    J Clin Microbiol; 1995 Sep; 33(9):2435-44. PubMed ID: 7494042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats.
    Fernández-Varón E; Cárceles-García C; Serrano-Rodríguez JM; Cárceles-Rodríguez CM
    BMC Vet Res; 2016 Oct; 12(1):232. PubMed ID: 27737655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigations on the effectiveness of cefazedone in experimental E. coli pyelonephritis.
    Sack K; Marre R; Freiesleben H; Henkel W
    Arzneimittelforschung; 1979; 29(2a):414-6. PubMed ID: 385009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease.
    Burton PJ; Thornsberry C; Cheung Yee Y; Watts JL; Yancey RJ
    J Vet Diagn Invest; 1996 Oct; 8(4):464-8. PubMed ID: 8953533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance.
    Salmon SA; Watts JL; Yancey RJ
    J Vet Diagn Invest; 1996 Jul; 8(3):332-6. PubMed ID: 8844576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between structure and biological properties of cephalosporins: the discovery of ceftriaxone.
    Reiner R
    Drugs Exp Clin Res; 1986; 12(4):299-302. PubMed ID: 3522153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparative stability of different types of penicillin and cephalosporin N-pyrryl derivatives.
    Arín MJ; Diez MT; Salto F
    Pharmazie; 1988 Jan; 43(1):18-9. PubMed ID: 3375293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Riemerella anatipestifer isolated from ducks and the efficacy of ceftiofur treatment.
    Chang CF; Lin WH; Yeh TM; Chiang TS; Chang YF
    J Vet Diagn Invest; 2003 Jan; 15(1):26-9. PubMed ID: 12580291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of respiratory infections in horses with ceftiofur sodium.
    Folz SD; Hanson BJ; Griffin AK; Dinvald LL; Swerczek TW; Walker RD; Foreman JH
    Equine Vet J; 1992 Jul; 24(4):300-4. PubMed ID: 1499539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships within a series of C(7)-substitutedoxyiminocephalosporins containing the C(3)-methylaminopyridiniumthiomethyl substituent. Synthesis and biological properties of BRL 57342 and some close analogues.
    Adams RG; Brain EG; Branch CL; Guest AW; Harrington FP; Mizen L; Neale JE; Pearson MJ; Simpson IN; Smulders H
    J Antibiot (Tokyo); 1995 May; 48(5):417-24. PubMed ID: 7797444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-Deacetoxy-7-(alpha-amino-1-cyclohexenylacetamido) cephalosporanic acid (SCE-100), a new semisynthetic cephalosporin. II. Comparative in vivo antibacterial activities of SCE-100 and cephalexin (CEX).
    Yamazaki T; Tsuchiya K
    J Antibiot (Tokyo); 1976 May; 29(5):566-70. PubMed ID: 1048101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semisynthetic cephalosporins. Synthesis and structure-activity relationships of 7-(1-pyrryl)- and 7-(1-indolyl)acetamidocephalosporin derivatives.
    Nudelman A; Karoly H; Braun F; Böhme EH; Erickson RC
    J Med Chem; 1978 Sep; 21(9):962-4. PubMed ID: 722761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diastereomeric 7-ureidoacetyl cephalosporins. II. 7beta [[[(Aminocarbonyl) amino]-2-thienylacetyl] amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl) thio] methyl]-8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic acid.
    Applegate HE; Cimarusti CM; Dolfini JE; Koster WH; Ondetti MA; Slusarchyk WA; Young MG; Breuer H; Treuner UD
    J Antibiot (Tokyo); 1978 Jun; 31(6):561-9. PubMed ID: 681237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.